The Diagnostic Imaging ultrasound modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of ultrasound across the healthcare continuum, from cardiovascular, breast, abdominal, neurological imaging, and more, including point-of-care ultrasound.
April 4th 2025
In a study recently presented at the American College of Cardiology (ACC) conference, researchers found that novice use of AI-guided cardiac ultrasound after an AI-enabled electrocardiogram increased the positive predictive value for reduced left ventricular ejection fraction (LVEF) or aortic valve stenosis by 33 percent.
Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment
April 4, 2025 | New York, NY & Virtual
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
MR elastography tops noninvasive staging of liver fibrosis
November 1st 2007Researchers in Belgium have found that MR elastography is more accurate than a blood test commonly used in the noninvasive staging of liver fibrosis. The study adds weight to clinical literature that suggests MR elastography could replace biopsy.
Ultrasound beats MRI at identifying deep endometriosis
October 29th 2007Transvaginal ultrasound is better at identifying cases of deep retrocervical and rectosigmoid endometriosis than MRI and clinical examination. It has better sensitivity, specificity, positive predictive value, negative predictive value, and accuracy, according to a recent study in Brazil.
Philips CFO deflects questions about RSNA unveilings
October 23rd 2007Digesting the mediocre performance by Philips Medical in the third quarter, financial analysts peppered Pierre-Jean Sivignon, chief financial officer of Koninklijke Philips Electronics, with questions about the company’s plans for the upcoming RSNA. They were looking for reasons to believe the CFO’s assertions that Philips’ financials would soon improve.
Ultrasound differentiates between hepatitis and cirrhosis
October 18th 2007Simple gray scale and color Doppler sonography can show differences between compensated liver cirrhosis and chronic viral hepatitis in patients with liver problems. Certain color Doppler indices can even help narrow down the stage of chronic viral hepatitis, reducing the need for biopsies.
Second point-of-care ultrasound unit debuts
October 16th 2007SonoSite unveiled its second hand-carried ultrasound unit in as many weeks. This one, like the one that came out Oct. 1, is focused on point-of-care ultrasound. Unlike the M-Turbo, however, which can handle a broad range of bedside applications, the S-FAST (Focused Assessment with Ultrasound for Trauma) was designed specifically for emergency medicine.
Barnes-Jewish drops echo contrast before FDA alert
October 15th 2007The Cardiac Diagnostic Laboratory at Barnes-Jewish Hospital in St. Louis has stopped using Definity, the echocardiographic contrast agent marketed by Bristol-Myers Squibb, according to an Oct. 11 memo obtained by Diagnostic Imaging.
Patient-controlled sedation for endoscopic ultrasound matches current standard
October 15th 2007Patient-controlled sedation and analgesia with a combination of propofol and fentanyl worked just as well as the standard gastroenterologist-administered midazolam and pethidine for upper gastrointestinal tract endoscopic ultrasound exams. Patients and endoscopists were equally satisfied with each method.
SonoSite exec discloses strategy underlying M-Turbo
October 9th 2007Point-of-care medicine took a step forward Oct. 1 with the release of SonoSite’s latest hand-carried ultrasound system. M-Turbo, so named because of its speed, offers improved image clarity and ease of use. This is achieved, according to the company, through a 16-fold increase in processing power that allows the running of several algorithms that reduce artifacts, boost spatial resolution, and match imaging parameters to exam type.
Doppler ultrasound predicts spread of endometrial cancer
October 8th 2007Doppler sonography and 3D power Doppler angiography can distinguish between endometrial cancer and hyperplasia, according to researchers in Spain. The standard measurement of endometrial thickness alone, however, did not significantly differentiate between the two conditions.
Black box warning planned for ultrasound microbubble contrast
October 8th 2007The commercial prospects of Definity and Optison, the only two ultrasound contrast media approved for clinical use in the U.S., may be damaged if the FDA moves ahead with plans to require black box warnings for the two echocardiography agents.
SonoSite exec explains strategy underlying M-Turbo
October 2nd 2007Point-of-care medicine took a step forward Oct. 1 with the release of SonoSite’s latest hand-carried ultrasound system. M-Turbo, so named because of its speed, offers improved image clarity and ease of use. This is achieved, according to the company, through a 16-fold increase in processing power that allows the running of several algorithms that reduce artifacts, boost spatial resolution, and match imaging parameters to exam type.
Sonographers worldwide face debilitating injuries
October 1st 2007Increasing volumes of work and demanding schedules, exacerbated by staff shortages and the pressures of working in a target-driven environment, contribute to the increased prevalence of musculoskeletal disorders among sonographers, according to leaders in the field.